Healthy VolunteersLSD

Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans

In a within-subjects study using a probabilistic reversal learning task and computational modelling, intravenous LSD (75 μg) increased reinforcement learning rates—more for reward than punishment—and decreased stimulus stickiness (greater exploratory behaviour), while leaving reinforcement sensitivity and win‑stay/lose‑shift probabilities unchanged. These effects suggest LSD induces a state of heightened plasticity that could facilitate revision of maladaptive associations relevant to psychiatric treatment.

Authors

  • Robin Carhart-Harris
  • David Nutt

Published

Psychological Medicine
individual Study

Abstract

The non-selective serotonin 2A (5-HT 2A ) receptor agonist lysergic acid diethylamide (LSD) holds promise as a treatment for some psychiatric disorders. Psychedelic drugs such as LSD have been suggested to have therapeutic actions through their effects on learning. The behavioural effects of LSD in humans, however, remain largely unexplored. Here we examined how LSD affects probabilistic reversal learning in healthy humans. Healthy volunteers received intravenous LSD (75μg in 10 mL saline) or placebo (10mL saline) in a within-subjects design and completed a probabilistic reversal learning task. Participants had to learn through trial and error which of three stimuli was rewarded most of the time, and these contingencies switched in a reversal phase. Computational models of reinforcement learning were fitted to the behavioural data to assess how LSD affected the updating (“learning rates”) and deployment (“reinforcement sensitivity”) of value representations during choice, as well as “stimulus stickiness”, which assays choice repetition irrespective of reinforcement history. Conventional measures assessing sensitivity to immediate feedback (“win-stay” and “lose-shift” probabilities) were unaffected, whereas LSD increased the impact of the strength of initial learning on perseveration. Computational modelling revealed that the most pronounced effect of LSD was enhancement of the reward learning rate. The punishment learning rate was also elevated. Stimulus stickiness was decreased by LSD, reflecting heightened exploratory behaviour, while reinforcement sensitivity was unaffected. Increased reinforcement learning rates suggest LSD induced a state of heightened plasticity. These results indicate a potential mechanism through which revision of maladaptive associations could occur in the clinical application of LSD. Significance statement The psychedelic (“mind-manifesting”) drug LSD holds promise for the treatment of some psychiatric disorders. Theories have postulated its therapeutic potential centres on enhancing learning and flexible thinking. Here we provide substantiating empirical evidence by examining the computations underlying behaviour as healthy volunteers learned through trial and error under LSD. Viewing choice as based on representations of an action’s value, LSD increased the speed at which value was updated following feedback, which was more pronounced following reward than punishment. Behaviour was also more exploratory under LSD, irrespective of the outcome of actions. These results indicate that LSD impacted a fundamental belief-updating process inherent in the brain which can be leveraged to revise maladaptive associations characteristic of a range of mental disorders.

Available with Blossom Pro

Research Summary of 'Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans'

Introduction

LSD is a non-selective 5-HT2A receptor agonist whose therapeutic potential in psychiatry has been increasingly discussed. Theoretical accounts posit that psychedelics promote plasticity and the revision of maladaptive beliefs, but objective tests of how LSD alters learning and cognitive flexibility in humans are limited. Serotonin and dopamine systems, both implicated in feedback-driven learning and flexibility, are candidate neurochemical mediators; translational work (including serotonergic depletion and dopaminergic manipulations in animals) shows these systems influence perseveration and sensitivity to reward and punishment. Kanen and colleagues set out to test whether acute LSD alters probabilistic reversal learning (PRL) in healthy volunteers and to characterise any effects using computational reinforcement learning models. The study specifically probed whether LSD changes sensitivity to immediate feedback (win-stay/lose-stay), the influence of previously acquired values on perseveration, and the rates at which value is updated after reward or punishment; it also examined a parameter indexing stimulus-driven choice independent of outcome ("stimulus stickiness").

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

  • Study Type
    individual
  • Journal
  • Compound
  • Topic
  • Authors
  • APA Citation

    Kanen, J. W., Luo, Q., Kandroodi, M. R., Cardinal, R. N., Robbins, T. W., Carhart-Harris, R. L., & den Ouden, H. E. (2020). Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans. https://doi.org/10.1101/2020.12.04.412189

References (14)

Papers cited by this study that are also in Blossom

Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study

Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A. et al. · Journal of Psychopharmacology (2015)

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up

Carhart-Harris, R. L., Bolstridge, &. M., Day, C. M. J. et al. · Psychopharmacology (2017)

REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics

Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)

Serotonin and brain function: a tale of two receptors

Carhart-Harris, R. L., Nutt, D. J. · Journal of Psychopharmacology (2017)

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Carhart-Harris, R. L., Bolstridge, M., Rucker, J. et al. · Lancet Psychiatry (2016)

1174 cited
Neural correlates of the LSD experience revealed by multimodal neuroimaging

Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L. et al. · PNAS (2016)

The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis

Goldberg, S. B., Pace, B. T., Nicholas, C. R. et al. · Psychiatry Research (2020)

Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer

Grob, C. S., Danforth, A. L., Chopra, G. S. et al. · JAMA Psychiatry (2011)

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction

Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P. et al. · Journal of Psychopharmacology (2014)

Show all 14 references
Nourishing the spirit: exploratory research on ayahuasca experiences along the continuum of recovery from eating disorders

Lafrance, A., Loizaga-Velder, A., Fletcher, J. et al. · Journal of Psychoactive Drugs (2017)

Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder

Moreno, F. A., Wiegand, C. B., Taitano, E. K. et al. · Journal of Clinical Psychiatry (2006)

Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders

Vollenweider, F. X., Preller, K. H. · Nature Reviews Neuroscience (2020)

Cited By (10)

Papers in Blossom that reference this study

The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial

Henry, J., Giribaldi, B., Nutt, D. J. et al. · European Neuropsychopharmacology (2025)

Safety, tolerability and subjective effects of vaporized N,N-Dimethyltryptamine: A randomized double-blind clinical trial

Wießner, I., Falchi-Carvalho, M., Laborde, S. et al. · European Neuropsychopharmacology (2025)

Synthetic surprise as the foundation of the psychedelic experience

De Filippo, R., Schmitz, D. · Neuroscience and Biobehavioral Reviews (2024)

Therapeutic mechanisms of psychedelics and entactogens

Heifets, B. D., Olson, D. E. · Neuropsychopharmacology (2023)

Canalization and plasticity in psychopathology

Carhart-Harris, R. L., Chandaria, S., Erritzoe, D. E. et al. · Neuropharmacology (2023)

Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity

Glazer', J., Murray, C. H., Nusslock', R. et al. · Neuropsychopharmacology (2022)

Towards an understanding of psychedelic-induced neuroplasticity

Calder, A. E., Hasler, G. · Neuropsychopharmacology (2022)

Pattern Breaking: A Complex Systems Approach to Psychedelic Medicine

Hipólito, I., Mago, J., Rosas, F. E. et al. · Psyarxiv (2022)

Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective

Dursun, S. M., Kelly, J. R., Gillan, C. M. et al. · Frontiers in Psychiatry (2021)

A continuum hypothesis of psychotomimetic rapid antidepressants

Haarsma, J., Harmer, C. J., Tamm, S. · Brain and Neuroscience Advances (2021)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.

Effect of lysergic acid diethylamide (LSD) on... — Research Summary & Context | Blossom